Tel: +998903350930
Search

Jild 11 Nomeri 1 (2025)
Central Asian Research Journal for Interdisciplinary Studies (CARJIS) special issue – medicine sciences

Articles

ASSESSMENT OF THE INTENSITY OF POST-VAC- CINATION IMMUNITY AGAINST MEASLES IN CHILDREN WHO HAVE HAD COVID-19

DOI 10.63294/afucon/vol11iss1/251 Google Scholar Google Scholar Betlar 316-321

Nashr qilingan 2025-11-30

Mualliflar
R. Z. Pulatova a , D.T. Kenjayeva b
Affiliations
a Alfraganus Universiteti image/svg+xml
b Toshkent davlat tibbiyot universiteti image/svg+xml
PDF (inglizcha)

Annotatsiya

The state of post-vaccination immunity to measles was studied in 178 previously vaccinated children with post-COVID syndrome aged 6 months to 12 years, as well as in 30 healthy children of the same age. The high frequency of seronegative cases of measles antibodies is associated with previously suffered COVID-19. The manifestation of the underlying disease over a long period of time, expressed in post-COVID syndrome, negatively affects the production of protective antibodies to measles in comparison with healthy children.

References

  1. Belhadjer Z., Meot M., Bajolle F. et al. Acute heart failure in multisystem inflammatory syn- drome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation. 2020; 142(5): 429–36. https://dx.doi.org/10.1161/CIRCULATIONAHA.120.048360
  2. Bobomuratov T.A, Karimova N.A, Tursunbayev A.K, Nurmatova N.F. Complications from the cardiovascular system in children who have had COVID-19./ E3S Web of Conferences.- 2023 |Conference paper. DOI:10.1051/e3sconf/202338101092
  3. Esper F., Shapiro E.D., Weibel C.et al. Association between a novel human coronavirus and Kawasaki disease /J. Infect Dis. – 2005. – V. 191. – P. 499-502
  4. Gomes, S Gonzales Martinez et al. //Lancet. – 2020. – V. 23. – P. 395(10237). – P. 1607- 1608
  5. Hennon T.R., Penque M.D., Aziz R.A. et al. COVID-19 associated Multisystem Inflam- matory Syndrome in Children (MIS-C) guidelines; a Western New York approach / //Prog. Pedi- atr. Cardiol. – 2020. 23:101232. Epub ahead of print. doi: 10.1016/j.ppedcard.2020.101232
  6. Kantemirova M.G., Novikova Yu.Yu., Ovsyannikov D.Yu. Pediatric pharmacology 17(3), 219–229 (2020). doi: 10.15690/pf.v17i3.2126
  7. Verdoni L., Mazza A., Gervasoni A. et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: An observational cohort study. Lancet. 2020; 395(10239): 1771–78. https://dx.doi.org/10.1016/S0140-6736(20)31103-X
  8. Whitaker E., Bamford A., Kenny J. et al. //JAMA. Publishtd online June 8 2020 doi 10.1001/ jama.2020.10369
  9. Whittaker E., Bamford A., Kenny J. et al. Clinical characteristics of 58 children with a pedi- atric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020; 324(3): 259–69. https://dx.doi.org/10.1001/jama.2020.10369
  10. Абатуров А.Е., Агафонова Е.А., Кривуша Е.Л., Никулина А.А. Патогенез COVID- 19 / Zdorov‘e Rebenka. – 2020. – №15 (2). – P. 133-144
  11. Зайратьянц О.В., Самсонова М.В., Михалева Л.М. и др. Патологическая анатомия COVID-19 /Атлас /Под общ. ред. О. В. Зайратьянца. – М.: ДЗМ, 2020. – 116 с
  12. Зверева Н.Н., Сайфуллин М.А., Ртищев А.Ю. и др. Коронавирусная инфекция у детей / Педиатрия. – 2020. – №99 (2). – С. 270-278
  13. Намазова-Баранова Л. С. Короновирусная инфекция (COVID-19) у детей (состо- яние на апрель 2020) //Педиатрическая фармакология. – 2020. – Т. 17. – №2. – С. 93-94

Yuklab olishlar

Yuklab olish ma’lumotlari hali mavjud emas.